Buyout (LBO, MBO, MBI) • Life Science

Artemis Capital Partners Acquires Millrock Technology

On September 30, 2025, private equity firm Artemis Capital Partners acquired life science company Millrock Technology

Acquisition Context
  • This is Artemis Capital Partners’ 1st transaction in the Life Science sector.
  • This is Artemis Capital Partners’ 17th transaction in the United States.
  • This is Artemis Capital Partners’ 1st transaction in New York.

Explore All 460 Buyout (LBO, MBO, MBI) Life Science Deals - Search the Database Free


M&A Deal Summary

Date September 30, 2025
Target Millrock Technology
Sector Life Science
Buyer(s) Artemis Capital Partners
Deal Type Buyout (LBO, MBO, MBI)
Advisor(s) Sperry, Mitchell & Company (Financial)
Seward & Kissel (Legal)

Target Company

Millrock Technology

Kingston, New York, United States
Millrock Technology specializes in laboratory, pilot, and production-scale lyophilizers, with advanced process control technologies designed to optimize efficiency, compliance, and scalability. Millrock Technology is based in Kingston, New York.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Artemis Capital Partners

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2010
Size Small
Type Sector Agnostic
DESCRIPTION

Artemis Capital Partners is a private equity firm focused on buyouts and growth equity investments in industrial technology businesses. Artemis likes businesses with unique and defensible products, technology and/or intellectual property. Specific areas of interest includes industrial automation and software, life sciences laboratory automation and software, controls, devices, sensors and instrumentation. Target companies generate revenues of $2 to $50 million and at least $500k of EBITDA. Artemis is based in Boston, Massachusetts.


Deal Context for Buyer #
Overall 19 of 19
Sector: Life Science 1 of 1
Type: Buyout (LBO, MBO, MBI) 13 of 13
State: New York 1 of 1
Country: United States 17 of 17
Year: 2025 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-01-08 Richland Glass

Vineland, New Jersey, United States

Richland Glass is an advanced materials manufacturer of specialty glass containment products and solutions that enable analysis of low-volume, high-value, microfluidic samples for life-saving applications at the frontier of human health and environmental security. Richland Glass is based in Vineland, New Jersey.

Buy -